GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease
The glial cell line-derived neurotrophic factor (GDNF) is a well-established trophic agent for dopaminergic (DA) neurons in vitro and in vivo. GDNF is necessary for maintenance of neuronal morphological and neurochemical phenotype and protects DA neurons from toxic damage. Numerous studies on animal...
Main Authors: | Xavier ed'Anglemont De Tassigny, Alberto ePascual, Jose eLopez-Barneo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-02-01
|
Series: | Frontiers in Neuroanatomy |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnana.2015.00010/full |
Similar Items
-
Dopamine Synthesis in the Nigrostriatal Dopaminergic System in Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage
by: Victor Blokhin, et al.
Published: (2024-02-01) -
Initial Molecular Mechanisms of the Pathogenesis of Parkinson’s Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease
by: Anna Kolacheva, et al.
Published: (2024-01-01) -
Aging of the Nigrostriatal Tract in the Human Brain: A Diffusion Tensor Imaging Study
by: Jeong-Pyo Seo, et al.
Published: (2021-09-01) -
Endogenous GDNF Is Unable to Halt Dopaminergic Injury Triggered by Microglial Activation
by: Julieta Mendes-Oliveira, et al.
Published: (2023-12-01) -
Two distinct degenerative types of nigrostriatal dopaminergic neuron in the early stage of parkinsonian disorders
by: Tomoya Kawazoe, et al.
Published: (2024-01-01)